Xencor, Inc. (XNCR)

23.80 -0.08 (-0.34%) USD  |  NASDAQ  |  Sep 25, 16:00
23.81 +0.01 (+0.04%) After-Hours: 19:59
More

Xencor Cash and Short Term Investments (Annual) : 547.73M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for XNCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2011. Start Trial.
Date Value
December 31, 2025 547.73M
December 31, 2024 497.78M
December 31, 2023 593.72M
December 31, 2022 621.76M
December 31, 2021 333.31M
December 31, 2020 601.60M
December 31, 2019 527.08M
December 31, 2018 292.06M
Date Value
December 31, 2017 222.43M
December 31, 2016 128.74M
December 31, 2015 96.43M
December 31, 2014 54.65M
December 31, 2013 77.98M
December 31, 2012 2.312M
December 31, 2011 14.54M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
UroGen Pharma Ltd. 121.81M
MeiraGTx Holdings Plc 65.93M
Regeneron Pharmaceuticals, Inc. 8.611B
Ironwood Pharmaceuticals, Inc. 215.46M
MacroGenics, Inc. 189.91M